[go: up one dir, main page]

WO2012021016A3 - Lactobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient - Google Patents

Lactobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient Download PDF

Info

Publication number
WO2012021016A3
WO2012021016A3 PCT/KR2011/005916 KR2011005916W WO2012021016A3 WO 2012021016 A3 WO2012021016 A3 WO 2012021016A3 KR 2011005916 W KR2011005916 W KR 2011005916W WO 2012021016 A3 WO2012021016 A3 WO 2012021016A3
Authority
WO
WIPO (PCT)
Prior art keywords
cancer activity
active ingredient
composition including
including same
lactobacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2011/005916
Other languages
French (fr)
Korean (ko)
Other versions
WO2012021016A9 (en
WO2012021016A2 (en
Inventor
박진형
박기범
김희정
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2012021016A2 publication Critical patent/WO2012021016A2/en
Publication of WO2012021016A3 publication Critical patent/WO2012021016A3/en
Publication of WO2012021016A9 publication Critical patent/WO2012021016A9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/245Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention was conceived from the discovery of anti-cancer activity in lactobacillus out of many types of bacteria isolated while observing food-derived fermentation strains having the ability to ferment lactobacillus in apples, and provides lactobacillus casei (accession no. KCCM11072) having anti-cancer activity and the anti-cancer activity composition including same as an active ingredient, which can be used as a medical supply or as a health supplement food.
PCT/KR2011/005916 2010-08-12 2011-08-11 Lacobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient Ceased WO2012021016A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100077908A KR20120015644A (en) 2010-08-12 2010-08-12 Lactobacillus strain having anticancer activity and anticancer active composition comprising the same as an active ingredient
KR10-2010-0077908 2010-08-12

Publications (3)

Publication Number Publication Date
WO2012021016A2 WO2012021016A2 (en) 2012-02-16
WO2012021016A3 true WO2012021016A3 (en) 2012-05-10
WO2012021016A9 WO2012021016A9 (en) 2012-06-28

Family

ID=45568066

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/005916 Ceased WO2012021016A2 (en) 2010-08-12 2011-08-11 Lacobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient

Country Status (2)

Country Link
KR (1) KR20120015644A (en)
WO (1) WO2012021016A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101910808B1 (en) * 2016-11-28 2018-10-24 주식회사 쎌바이오텍 Protein P8 Derived from Lactic Acid Bacteria and Its Use as Anti-Caner Agent
KR102680587B1 (en) * 2018-05-28 2024-07-03 주식회사 쎌바이오텍 Active Fragment Peptide of Protein Derived from Lactic Acid Bacteria and Use of the Same
KR102457422B1 (en) * 2022-05-04 2022-10-21 주식회사 메디오젠 Composition for preventing or treating colorectal cancer comprising a mixed strain of probiotics
CN116948916B (en) * 2023-08-11 2024-06-11 四川大学 Lactobacillus casei and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000038058A (en) * 1998-12-03 2000-07-05 이은선 New lactobacillus casei ky 22713 which ferments mistletoe
WO2003045405A2 (en) * 2001-11-27 2003-06-05 Bio-K Plus International Inc. Lactic acid bacteria and their use for treating and preventing cancer
KR100411198B1 (en) * 2001-03-13 2003-12-18 매일유업주식회사 Formulation for inhibiting proliferation of tumor cell line
KR20100008831A (en) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 Anti-cancer composition comprising a culture fluid of lactobacillus casei as an effective component

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000038058A (en) * 1998-12-03 2000-07-05 이은선 New lactobacillus casei ky 22713 which ferments mistletoe
KR100411198B1 (en) * 2001-03-13 2003-12-18 매일유업주식회사 Formulation for inhibiting proliferation of tumor cell line
WO2003045405A2 (en) * 2001-11-27 2003-06-05 Bio-K Plus International Inc. Lactic acid bacteria and their use for treating and preventing cancer
KR20100008831A (en) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 Anti-cancer composition comprising a culture fluid of lactobacillus casei as an effective component

Also Published As

Publication number Publication date
WO2012021016A9 (en) 2012-06-28
WO2012021016A2 (en) 2012-02-16
KR20120015644A (en) 2012-02-22

Similar Documents

Publication Publication Date Title
MY172363A (en) Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
RU2013153578A (en) POLYBACTERIAL DRUG WITH ADVANTAGES FOR HEALTH: WITH ANTIOXIDANT EFFECT, REDUCED CONCENTRATION OF CHOLESTEROL, ANTI-INFLAMMATIVE EFFECT AND SUSTAINABILITY
EP4257194A3 (en) Use of microbial communities for human and animal health
UA46234U (en) Composition of ingredients of bread kvass
WO2009013709A3 (en) Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same
WO2009142472A3 (en) Bifidobacteria that produces folic acid, food composition and use of said bifidobacteria
MX355955B (en) Synergistic antimicrobial effect.
RU2010147343A (en) ISOLATED microorganism strain Lactobacillus plantarum Inducia DSM 21379 as probiotics, strengthens Innate immunity of the body, products, and compositions containing UPOMOMYANUTY microorganisms, and the use of said microorganisms for the preparation of a medicament that enhances the Cellular immunity
ATE551419T1 (en) BACTERIAL STRAIN WITH ANTIALLERGIC ACTIVITY AND DRINK, FOOD AND ANTIALLERGIC DRUG WITH CELL OF THE BACTERIA STRAIN
UA118250C2 (en) APPLICATION OF LACTIC ACID BACTERIA TO OBTAIN ENZYMED FOODSTUFFS WITH INCREASED NATURAL SWEET
IN2012DN01638A (en)
MX2013004343A (en) Texturizing lactic acid bacteria strains.
WO2011162523A3 (en) Composition for preventing or treating osteoporosis, containing ssangwhatang or lactobacillus fermented product thereof
WO2009066681A1 (en) Lactic acid bacterium-containing preparation
MX339951B (en) Bacillus subtilis isolate from corn.
MX337716B (en) Lactic acid bacterium-containing preparation.
EP1812023B8 (en) Lactic acid bacteria as probiotic strains and compositions containing same
MX2012007970A (en) Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field.
IN2012DN02283A (en)
WO2012021016A3 (en) Lactobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient
TW200700074A (en) Inducer of t cell apoptosis
WO2011031145A3 (en) Improved soy milk fermentation
WO2011073769A3 (en) Conjugated linoleic acid-producing strains of probiotic bacteria and use thereof for the preparation of a food, dietetic or pharmaceutical composition
CA2567976A1 (en) A composition having immunoregulating activities comprising lactobacillus pentosus
WO2006119780A3 (en) New antibiotic-sensitive lactic acid bacteria strains

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11816632

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11816632

Country of ref document: EP

Kind code of ref document: A2